What You Should Know:
– Salesforce (NYSE: CRM), the world’s #1 CRM, today announced that AstraZeneca (LSE/STO/Nasdaq: AZN), a global, science-led biopharmaceutical company, has selected Agentforce Life Sciences for Customer Engagement to help transform its customer engagement…
Continue Reading
IPO Launch Details
Nephrocare Health Services, operating under the renowned Nephroplus brand, has officially filed its Red Herring Prospectus (RHP) with the Registrar of Companies, marking a significant milestone in India’s healthcare sector. The company,…
Kidney transplantation offers life-extending treatment for patients with end-stage renal disease, yet long-term risks of graft loss and death persist. Traditional prediction models using only baseline data often fail to capture patients’ evolving health…
Continue Reading
Patients with clear cell renal cell carcinoma (ccRCC) face a high risk of recurrence after surgery, but existing clinical tools based on clinicopathological factors or costly molecular profiling often lack precision and clinical feasibility….
Continue Reading
Little is known about the prognostic value of continuous, out-of-clinic biometric monitoring of cardiovascular function in chronic kidney disease (CKD). In this study, a mean (±SD) of 50.3 ± 9.3 h of EKG recordings from wearable BioPatch…
Continue Reading
Digital Health Pitchfest finalist Kidney Beam’s digital rehabilitation and self-management platform has been recommended by Health Technology Wales (HTW) for people living with chronic kidney disease.
Kidney Beam’s digital platform offers live and on-demand exercise,…
What You Should Know:
– Nuclear Care Partners, a leading provider of specialized in-home care for former Department of Energy (DOE) and nuclear weapons workers, has announced the launch of Care+ Kidney.
– The new program…
Continue Reading
Preoperative detection of pT3a invasion in non-metastatic renal cell carcinoma (RCC) remains challenging with CT. This study developed and validated radiomic models using preoperative CT to identify pT3a invasions. Six models were trained and…
Continue Reading
Sir Professor Stephen Powis, national medical director at NHS England, has called for patients and the public to be more involved in digital transformation.
Speaking in a spotlight session at Digital Health Rewired on 19…
Differentiating between diabetic nephropathy (DN) and non-diabetic renal disease (NDRD) without a kidney biopsy remains a major challenge, often leading to missed opportunities for targeted treatments that could greatly improve NDRD outcomes. To reform…
Continue Reading
